INDICATION: For treatment of respiratory disorders complicated by bronchospasm and excessive secretion of tenacious mucus, bronchial asthma, chronic bronchitis and emphysema. FDA REG. NO.: DR-XY40805
INDICATION: For treatment of respiratory disorders complicated by bronchospasm and excessive secretion of tenacious mucus, bronchial asthma, chronic bronchitis and emphysema. FDA REG. NO.: DR-XY40804
Indication: For the management of reversible airways obstruction, as in asthma and in some patients with chronic obstructive pulmonary diseases. It is also used as prophylactic agent for premature labor. FDA Reg. No.: DRP-2390-02
